Pharmacological management of cardiovascular risk in chronic inflammatory rheumatic diseases.
Vasileios PanoulasGeorge D KitasPublished in: Expert review of clinical pharmacology (2020)
CVD risk is increased in people with chronic inflammatory rheumatic diseases. Cardiovascular risk factor management is an essential part of their care. Although relevant guidance exists, there are still major gaps in knowledge and risk factor management implementation in these patient groups. Some practical guidance based on our interpretation of existing data and experience in the field is provided in this review.